Fragment, CJC1295, Ipamorelin 12mg (Blend)

Fragment 176-191, CJC-1295, Ipamorelin 12mg Blend — Advanced Peptide Stack for Fat Loss & Growth Hormone Optimization

The Fragment, CJC-1295, Ipamorelin 12mg Blend is a meticulously formulated tri-peptide research compound engineered to deliver synergistic growth hormone (GH) stimulation, accelerated fat metabolism, and enhanced lean muscle preservation. Combining three of the most studied and respected peptides in modern research pharmacology, this high-potency blend is designed for researchers seeking a comprehensive, single-vial solution that targets multiple pathways of the GH axis simultaneously.

Each vial contains a precision-measured 12mg total peptide content — a concentrated dose that represents a serious research-grade formulation suitable for advanced experimental protocols.

What Is the Fragment, CJC-1295 & Ipamorelin 12mg Blend?

This blend combines three distinct peptide compounds — Fragment 176-191, CJC-1295 (with or without DAC), and Ipamorelin — each selected for their complementary mechanisms of action. Together, they form a synergistic stack that research suggests may amplify GH pulsatile release, promote lipolysis (fat breakdown), and support anabolic tissue processes.

Fragment 176-191 — The Fat-Targeting Peptide

Fragment 176-191 is a stabilized analogue of the C-terminal region of human growth hormone (hGH). Specifically, it corresponds to amino acids 176 through 191 of the hGH sequence. Research indicates that this fragment retains the fat-metabolizing properties of full-length GH while minimizing the proliferative and insulin-desensitizing effects associated with the full molecule.

Preclinical studies have demonstrated that Fragment 176-191 may:

• Stimulate lipolysis (the breakdown of stored fat) in adipocytes
• Inhibit lipogenesis (the formation of new fat cells)
• Improve insulin sensitivity at research-relevant doses
• Avoid receptor desensitization associated with full-length GH
• Act preferentially on adipose tissue, particularly abdominal fat deposits

CJC-1295 — The Long-Acting GHRH Analogue

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH). It is engineered to extend the half-life of native GHRH from minutes to days, depending on whether the DAC (Drug Affinity Complex) modification is present. CJC-1295 binds to albumin in the bloodstream, which dramatically prolongs its duration of action and produces sustained elevations in baseline GH levels.

In research contexts, CJC-1295 has been associated with:

• Increased mean plasma GH concentrations
• Elevated IGF-1 levels, a key downstream growth factor
• Sustained GH release without tachyphylaxis (receptor downregulation) over multi-week protocols
• Improved body composition markers in animal and early human studies
• Enhanced recovery and tissue repair signaling

Ipamorelin — The Selective GH Secretagogue

Ipamorelin is a pentapeptide that acts as a selective ghrelin receptor agonist (GHS-R1a). It triggers strong, pulsatile GH release without the side-effect profile associated with other secretagogues such as GHRP-2 or GHRP-6. Specifically, Ipamorelin does not cause significant cortisol elevation, prolactin release, or appetite stimulation at standard research doses — making it one of the cleanest GH secretagogues available for scientific investigation.

Research into Ipamorelin suggests it may:

• Produce robust, dose-dependent GH pulses
• Selectively target the pituitary without stimulating adrenal cortisol pathways
• Support lean muscle anabolism via downstream IGF-1 activity
• Improve sleep quality and recovery through GH-mediated mechanisms
• Combine synergistically with GHRH analogues like CJC-1295 to amplify total GH output

Why Choose a Peptide Blend Over Individual Compounds?

Researchers frequently combine peptides to exploit synergistic receptor activation across multiple GH-axis pathways. The Fragment + CJC-1295 + Ipamorelin combination addresses three distinct targets simultaneously:

• Fragment 176-191 acts directly on adipose tissue at the peripheral level, independently of pituitary GH secretion.
• CJC-1295 upregulates baseline GH through sustained GHRH receptor activation — the ‘tonic’ or baseline GH release component.
• Ipamorelin drives acute, pulsatile GH release through the ghrelin pathway — the ‘spike’ component of GH secretion.

By combining these three mechanisms in a single 12mg blend vial, researchers benefit from convenience, dosing consistency, and a potentially more comprehensive activation of the GH axis than any single peptide could achieve alone.

Product Specifications & Quality Standards

Technical Specifications

• Total Peptide Content: 12mg per vial
• Composition: Fragment 176-191 / CJC-1295 / Ipamorelin (blend ratio available on request)
• Purity: ≥98% by HPLC analysis
• Form: Lyophilized (freeze-dried) white powder
• Reconstitution: Sterile bacteriostatic water (not included)
• Storage: Lyophilized powder stable at room temperature; store reconstituted solution at 2–8°C
• Shelf Life: 24 months (lyophilized); 28–30 days (reconstituted, refrigerated)
• Packaging: Sealed amber glass vial with rubber stopper and aluminum crimp cap
• Certificate of Analysis: Available upon request

Quality Assurance & Purity Testing

All peptide blends are synthesized using solid-phase peptide synthesis (SPPS) methodology and undergo rigorous third-party analytical verification, including:

• High-Performance Liquid Chromatography (HPLC) for purity verification
• Mass Spectrometry (MS) for molecular identity confirmation
• Endotoxin (LAL) testing to ensure pyrogen-free product
• Amino acid composition analysis
• Sterility testing for vial integrity

Research Applications of Fragment, CJC-1295 & Ipamorelin Blend

Body Composition & Metabolic Research

This blend is widely used in preclinical metabolic research investigating adipose tissue reduction, lean mass preservation, and substrate partitioning. The inclusion of Fragment 176-191 makes this compound particularly relevant for studies focused on visceral and subcutaneous fat mobilization without the hyperglycemic effects associated with full hGH.

Growth Hormone Axis Modulation Research

The CJC-1295 and Ipamorelin combination represents one of the most cited dual-pathway GH stimulation models in peptide research. The GHRH + ghrelin receptor co-activation approach allows researchers to study GH pulse dynamics, IGF-1 downstream signaling, and the long-term effects of sustained GH axis stimulation on multiple tissue types.

Anti-Aging & Longevity Research

Age-related decline in GH and IGF-1 secretion is well-documented. Researchers studying the biological mechanisms of somatopause — the progressive reduction in GH output with aging — frequently employ blends

like this one to evaluate the potential for restored GH pulsatility and its downstream effects on bone density, skin collagen synthesis, mitochondrial function, and cognitive performance.

Recovery & Tissue Repair Studies

The anabolic signaling triggered by elevated GH and IGF-1 is of significant interest in research related to wound healing, musculoskeletal repair, tendon regeneration, and post-injury recovery protocols. This blend provides researchers with a means to study these pathways in vivo and in vitro with high peptide purity and consistent dosing.

Storage, Handling & Reconstitution Guidance

Proper storage and reconstitution are critical for maintaining the integrity and potency of lyophilized peptide blends. Follow these research-standard guidelines:

• Store lyophilized vials at 2–8°C (refrigerator) or below -20°C (freezer) for long-term storage. Avoid repeated freeze-thaw cycles.
• Reconstitute using sterile bacteriostatic water (0.9% benzyl alcohol) for extended post-reconstitution stability.
• Inject reconstitution solvent slowly against the inside wall of the vial — do not spray directly onto the lyophilized cake.
• Gently swirl — never shake — to dissolve. Complete dissolution should occur within 30–60 seconds.
• Once reconstituted, store at 2–8°C and use within 28–30 days.
• Protect from UV light. Do not store in direct sunlight.
• Label each vial with reconstitution date and concentration for accurate research record-keeping.

Why Source Your Peptide Blend from Us?

• Third-Party Verified Purity — Every batch is tested by independent HPLC and MS laboratories with COAs available.
• Research-Grade Manufacturing — Synthesized under strict quality controls using SPPS methodology.
• Lyophilized for Maximum Stability — Freeze-dried format ensures potency through shipping and storage.
• Discreet, Fast Shipping — Secure packaging with express delivery options available.

• Expert Support — Our team is available to answer research protocol questions and assist with product selection.
• Satisfaction Guaranteed — We stand behind every vial we ship with a quality guarantee.

Frequently Asked Questions

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 with DAC (Drug Affinity Complex) binds to serum albumin, extending its half-life to approximately 6–8 days. Without DAC (also known as Mod GRF 1-29), the half-life is approximately 30 minutes, producing more natural, pulsatile GH release patterns. The version included in your blend will be specified on your Certificate of Analysis.

Why is a 12mg vial preferable for research?

A 12mg vial provides sufficient peptide mass for extended research protocols without requiring frequent reordering. Combined with the blend’s three-component synergy, it reduces reconstitution steps and ensures consistent ratios across every dose administered in a study.

How should this blend be stored before reconstitution?

The lyophilized peptide blend is stable at room temperature (below 25°C) for short-term transport, but should be stored at 2–8°C for standard use or at -20°C for long-term archival. Once reconstituted, refrigerate at 2–8°C and use within 28–30 days.

Is a Certificate of Analysis available?

Yes. A full third-party Certificate of Analysis (COA) confirming purity, molecular identity, and endotoxin status is available for every batch. Contact our support team with your order number to request your batch-specific COA.

Order Fragment, CJC-1295, Ipamorelin 12mg Blend Today

Advance your research with one of the most comprehensive GH-axis peptide blends available. Our Fragment, CJC-1295, Ipamorelin 12mg Blend delivers verified purity, precise formulation, and the synergistic power of three proven research peptides in every vial. Place your order today and receive fast, discreet shipping with full quality documentation